Patent · US Active

Form of hexyl-5-aminolevulinate hydrochloride and methods of using the same

US8927761B2 · kind B2 · utility

2Cited by
0References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 28, 2013
Grant dateJan 6, 2015
Priority date
Expiry dateJun 28, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to a novel crystalline polymorph of hexyl-5-aminolevulinate hydrochloride, referred to hereinafter as Form C, which is useful as precursor of a photo sensitizer in the photodynamic diagnosis and treatment of metabolically active cells related to diseases such as cancer of the uterus, cervix, vagina, rectum, colon, lower gastrointestinal tract; infection associated with cancer caused by human papilloma virus; non-cancerous lower gastrointestinal tract a human; inflammatory bowel disease; ulcerative colitis; Crohn's disease; inflammatory bowel syndrome; dysplasia of the female reproductive system; anus; penis; rosacea; and acne and which is suitable for use as the active ingredient of a commercial pharmaceutical product. The invention relates further to methods of preparing Form C and using it in the described pharmaceutical compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.